Furthermore, associations between serum IP-10 and HCV spontaneous clearance have shown the value of serum IP-10 for the early diagnosis of hepatic fibrosis and treatment outcomes with IFN-based therapy in patients with chronic hepatitis C (CHC)16, 17, 18, 19, 20, 21. This evidence concerns the gene CXCL10 and cryohydrocytosis.